Increased mRNA levels of Mn-SOD and catalase in embryos of diabetic rats from a malformation-resistant strain

Diabetes

Volumn 49, Issue 1, 2000, Pages 101-107

  Cederberg, Jonas ^a   Galli, Joakim ^b   Luthman, Holger ^b   Eriksson, Ulf J ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; COMPLEMENTARY DNA; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EMBRYO; ENZYME ACTIVITY; GENE; GENETIC PREDISPOSITION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033961243     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.1.101     Document Type: Article

References (59)

1. Mølsted-Pedersen L, Tygstrups I, Pedersen J: Congenital malformations in newborn infants of diabetic women: correlation with maternal diabetic vascular complications. Lancet i:1124-1126, 1964
2. Kucera J: Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7:61-70, 1971
3. Pedersen JF, Mølsted-Pedersen L: Early growth retardation in diabetic pregnancy. Br Med J 4:1-5, 1979
4. Mills JL: Malformations in infants of diabetic mothers. Teratology 25:385-394, 1382
5. Hanson U, Persson B, Thunell S: Relationship between haemoglobin Alc in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia 33:100-104, 1990
6. Nordström L, Spetz E, Wallström K, Walinder O: Metabolic control and pregnancy outcome among women with insulin-dependent diabetes mellitus: a twelve-year follow-up in the country of Jaintland, Sweden. Acta Obstet Gynerol Scand 77:284-289, 1998
7. Casson I, Clarke C, Howard C, McKendrick O, Pennycook S, Pharoah P, Platt M, Stanisstreet M, van Velszen D, Walkinshaw S: Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 315:275-278, 1997
8. Hawthorne G, Robson S, Ryall EA, Sen D, Roberts SH, Ward Platt MP: Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit. BMJ 315:279-281, 1997
9. von Kries R, Kimmerle R, Schmidt JE, Hachmeister A, Bohm O, Wolf HG: Pregnancy outcome in mothers with pregestational diabetes: a population based study in North Rhine (Germany) from 1988 to 1993. Eur J Pediatr 156:963-967, 1997
10. Mills JL, Baker L, Goldman AS: Malformations in infants of diabetic mothers occur before the seventh gestational week: implications for treatment. Diabetes 28:292-293, 1979
11. Eriksson UJ, Bone AJ, Turnbull DM, Baird JD: Timed interruption of insulin therapy in diabetic BB/E rat pregnancy: effect on maternal metabolism and fetal outcome. Acta Endocrinol 120:800-810, 1989
12. Vercheval M, De Hertogh R, Pampfer S, Vanderheyden I, Michiels B, De Bernardi P, De Meyer R: Experimental diabetes impairs rat embryo development during the preimplantation period. Diabetologia 10:187-191, 1990
13. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM: Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 4:1421-1424, 1998
14. Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, Kitzmiller JL: Elevated maternal hemoglobin Alc in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304:1331-1334, 1981
15. Nielsen G, Sorensen H, Nielsen P, Sabroe S, Olsen J: Glycosylated hemoglobin as predictor of adverse fetal outcome in type 1 diabetic pregnancies. Acta Diabetol 34:217-222, 1997
16. Eriksson UJ, Borg LAH: Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:325-331, 1991
17. Eriksson UJ, Borg LA: Diabetes and embryonic malformations: role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419, 1993
18. Viana M, Herrera E, Bonet B: Teratogenic effects of diabetes mellitus in the rat: prevention with vitamin E. Diabetologia 39:1041-1046, 1996
19. Sivan E, Lee Y-C, Wu Y-K, Reece EA: Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats. Teratology 56:343-349, 1997
20. Kaplan P, Racay P, Lehotsky J, Mezesova V: Change in fluidity of brain endoplasmic reticulum membranes by oxygen free radicals: a protective effect of stobadine, alpha-tocopherol acetate, and butylated hydroxytoluene. Neurochem Res 20:815-820, 1995
21. Gutteridge JM, Halliwell B: The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15:129-135, 1990
22. Mattson MP: Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci 21:53-57, 1998
23. Imlay JA, Linn S: DNA damage and oxygen radical toxicity. Science 240:1302-1309, 1988
24. Elgawish A, Glomb M, Friedlander M, Monnier VM: Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J Biol Chem 271:12904-12971, 1996
25. Simán CM, Eriksson UJ: Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 46:1054-1061, 1997
26. Yang X, Borg LAH, Eriksson UJ: Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 272:E173-E180, 1997
27. Trocino RA, Akazawa S, Ishibashi M, Matsumoto K, Matsuo H, Yamamoto H, Goto S, Urata Y, Kondo T, Nagataki S: Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44:992-998, 1995
28. Wentzel P, Welsh N, Eriksson UJ: Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered PGE2 levels in rat embryos exposed to a diabetic environment. Diabetes 48:813-820, 1990
29. Jenkinson PC, Anderson D, Gangolli SD: Malformations induced in cultured rat embryos by enzymatically generated active oxygen species. Teratog Carcinog Mutagen 6:547-554, 1986
30. Eriksson UJ, Simán CM: Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in the offspring. Diabetes 45:1497-1502, 1996
31. Simán CM, Eriksson UJ: Malformations in the offspring of diabetic rats are prevented by supplementation of the maternal diet with vitamin C. Diabetologia 40:1416-1424, 1997
32. Winitzer A, Ayalon N, Hershkovitz R, Khamaisi M, Reece E, Trischler H, Bashan N: Lipoic acid prevention of neural tube defects in offspring of rats with streptozorin-induced diabetes. Am J Obstet Gynecol 180:188-193, 1999
33. Anderson D, Francis AJ: The modulating effects of antioxidants in rat embryos and Sertoli cells in culture. Basic Life Sci 61:189-200, 1993
34. Chen S-Y, Sulik K: Free radicals and ethanol-induced cytotoxicity in neural crest cells. Alcohol Clin Exp Res 20:1071-1076, 1996
35. Winn L, Wells P: Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity. Free Radic Biol Med 20:206-274, 1999
36. Parnman T, Wiley M, Wells P: Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat Med 5:582-585, 1999
37. Menegola M, Broccia M, Prati M, Ricolfi R, Giavini E: Glutathione status in diabetes-induced embryopathies. Biol Neonate 69:293-297, 1996
38. Eriksson UJ: Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology 37:365-374, 1988
39. Cederberg J, Eriksson UJ: Decreased catalase activity in malformation-prone embryos of diabetic rats. Teratology 56:350-357, 1997
40. Eriksson UJ, Den Bieman M, Prins JB, van Zutphen LFM: Differences in susceptibility for diabetes-induced malformations in separated rat colonies of common origin. In Proceedings of the 4th FELASA Symposium, Lyon, France, Lyon, France, Fondation Marcel Mérieux, 1990, p. 53-57
41. Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H: Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Biotechnology 24:17-27, 1986
42. Winer BJ: Statistical Principles in Experimental Design. New York: McGraw-Hill, 1971
43. Forsberg H, Borg LAH, Cagliero E, Eriksson UJ: Altered levels of scavenging enzymes in embryos subjected to a diabetic environment. Free Radic Res 24:451-459, 1996
44. Pampfer S, de Hertogh R, Vanderheyden I, Michiels B, Vercheval M: Decreased inner cell mass proportion in blastocysts from diabetic rats. Diabetes 39:471-476, 1990
45. Furuta S, Hayashi B, Hijikata M, Miazawa S, Osumi T, Hashimoto T: Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver catalase. Proc Natl Acad Sci U S A 83:313-317, 1986
46. Nakashima H, Yamamoto M, Goto K, Takashi O, Hashimoto Y, Endo H: Isolation and characterization of the rat catalase-encoding gene. Gene 79:279-288, 1989
47. van Remmen H, Williams M, Yang H, Walter C, Richardson A: Analysis of the transcriptional activity of the rat catalase gene in transiently transfected cells and in transgenic mice. J Cell Physiol 174:18-26, 1998
48. Sano T, Umeda F, Hashimoto T, Nawata H, Utsumi H: Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. Diabetologia 41:1355-1360, 1998
49. Sohal RS, Brunk UT: Mitochondrial production of pro-oxidants and cellular senescence. Mutat Res 275:295-304, 1992
50. Wentzel P, Jansson L, Eriksson UJ: Diabetes in pregnancy: uterine blood flow and embryonic development in the rat. Pediatr Res 38:598-606, 1995
51. Trocino R, Akazawa S, Takino H, Takao Y, Matsumoto K, Maeda Y, Okuno S-I, Nagataki S: Cellular-tissue localization and regulation of the GLUT-1 protein in both the embryo and the visceral yolk sac from normal and experimental diabetic rats during the early postimplantation period. Endocrinology 134:869-878, 1964
52. Yang W, Borg LAH, Simán CM, Eriksson UJ: Maternal antioxidant treatments prevent diabetes-induced alterations of mitochondrial morphology in rat embryos. Anat Rec 251:303-315, 1998
53. Hagay ZJ, Weiss Y, Zusman I, Peled KM, Reece EA, Eriksson UJ, Groner Y: Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 173:1036-1041, 1995
54. el-Hage S, Singh SM: Temporal expression of genes encoding free radical-metabolizing enzymes is associated with higher mRNA levels during in utero development in mice. Dev Genet 11:149-159, 1990
55. Phelan SA, Ito M, Loeken MR: Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46:1189-1197, 1997
56. Ratan RR, Murphy TH, Baraban JM: Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem 62:376-379, 1994
57. Sadler LS, Robinson LK, Msall ME: Diabetic embryopathy: possible pathogenesis. Am J Med Gen 55:363-366, 1995
58. Simán M: Congenital malformations in experimental diabetic pregnancy: actiology and antioxidative treatment. Uppsala J Med Sci 102:61-98, 1997
59. Suzuki N, Svensson K, Eriksson UJ: High glucose concentration inhibits migration of rat cranial neural crest cells in vitro. Diabetologia 39:401-411, 1996